Quality of Life (QOL), a construct which has not yet achieved precise definition in the medical literature, nonetheless is a necessary outcome variable requiring measurement in determining comprehensive menopausal status in the clinical context or as part of pivotal regulatory trial research. Current QOL measures are mostly symptom inventories or scores relating to specific life phases or diseases.
Reprinted with permission
COGI Paris
Quality of Life (QOL), a construct which has not yet achieved precise definition in the medical literature, nonetheless is a necessary outcome variable requiring measurement in determining comprehensive menopausal status in the clinical context or as part of pivotal regulatory trial research. Current QOL measures are mostly symptom inventories or scores relating to specific life phases or diseases.
We have reported on the Utian Quality of Life (UQOL) instrument. This is a brief instrument which measures QOL during the perimenopausal years through a 23-item questionnaire which demonstrates four separate intercorrelated domains. The UQOL with its simplicity of administration should be of practical value in clinical practice in evaluating QOL and changes in QOL in different communities and cultures.
Unfortunately, at this time, no such validated tool has been used in clinical studies, although the UQOL is currently being tested in HRT trials.
In the absence of definitive data, only speculation can be made as to whether HRT enhances QOL.
Study links premature menopause to musculoskeletal pain and sarcopenia risks
May 1st 2024A recent study revealed an association between premature menopause and increased risks of musculoskeletal pain and sarcopenia, emphasizing the potential benefits of hormone therapy in mitigating long-term effects.
Read More